Analysis of China's pharmaceutical intermediate market size, production, competitive pattern and key enterprises in 2023

At present, China's pharmaceutical intermediate industry has a high degree of marketization. As a whole, it has the characteristics of more small and medium-sized enterprises, concentrated production areas, stable business scale, low technological level, and serious product homogenization. The difficulty of new product development is becoming more and more difficult, and the competition for traditional products is becoming more and more fierce. Coupled with the influence of national environmental protection policies, the market size of the pharmaceutical intermediate industry has declined and grown slowly.In 2018, the market size of China's pharmaceutical intermediates industry was about 201.7 billion yuan, down 24% year-on-year: the industry will return to positive growth in 2020.

Analysis of the development of the global and Chinese fine chemical industry from 2023 to 2028

Fine chemical industry refers to the industry that produces fine chemicals, commonly known as the fine chemical industry.Products in this industry refer to chemical products with specific application functions, technology-intensive, strong commercial nature, and high product added value.

The market size and future development trend of China's pharmaceutical intermediate industry

China's pharmaceutical intermediate industry is an important part of China's pharmaceutical industry and an important force in promoting the development of China's pharmaceutical industry.In recent years, with the development of China's pharmaceutical industry, China's pharmaceutical intermediate industry has also made great strides.

Analysis of the development of the global and Chinese API industry from 2023 to 2028

API refers to raw materials that meet the requirements of relevant laws and regulations on drug administration and are used in the production of various types of drugs. They are the active ingredients in drugs.Perfect definition in ICH Q7A: Any substance or mixture of substances intended to be used in the manufacture of medicines, and when used in pharmaceuticals, it becomes an active ingredient of medicines.Such substances have pharmacological activity or other direct effects in the diagnosis, treatment, symptom relief, treatment or prevention of diseases, or can affect the function or structure of the body.

Yantai Yuchen Biological Medicine Co., Ltd. New website operation opened

YanTai YuChen Biological Medicine Co. Ltd. is a hi-tech enterprise integrating R&D, production and marketing, and sits at Laiyang, Shandong Province. Our institute boasts a professional R&D team and a production base engaged in research and development, production and marketing of active pharmaceutical ingredients and intermediates. Now, our products include active pharmaceutical ingredients such as tiotropium bromide and dofetilide; piperidinemethanol, ethyl isonipecotate/methyl isonipecotate, piperidinecarboxylicacid and other intermediates and pyridine carboxylic acid, pyridinecarboxaldehyde and other derivants.

Expert interpretation: Judge the clinical selection of tiotropium bromide from three angles!

At present, the prevention and treatment situation of chronic obstructive pulmonary disease in the world is serious.As the current first-line drug for the treatment of chronic obstructive pulmonary disease, tiotropium bromide, the quality of its inhalant products has an important impact on the clinical efficacy and safety. Recently, the "Quality Evaluation of Tiotropium Bromide Inhalation Powder Mist from Different Manufacturers-Experimental Research Report" (hereinafter referred to as the "Report") carried out by Professor Sha Xianyi of the School of Pharmacy of Fudan University and others was published.The study compared the relevant substances and indicators of the characteristics of the inhalation powder mist of tiotropium bromide produced by different domestic and original research manufacturers, and aims to provide a reference and basis for clinical medication.